Approvals/TGA/CIPTUNEC adalimumab 80 mg/0.8 mL solution for subcutaneous injection pre-filled syringe

Approved

STANDARD

CIPTUNEC adalimumab 80 mg/0.8 mL solution for subcutaneous injection pre-filled syringe

Cipla Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 7893c806d294f12e
Product Name: CIPTUNEC adalimumab 80 mg/0.8 mL solution for subcutaneous injection pre-filled syringe
Artg Id: 374374
Artg Name: CIPTUNEC adalimumab 80 mg/0.8 mL solution for subcutaneous injection pre-filled syringe
Sponsor: Cipla Australia Pty Ltd
Company Detail Path: /organization/cipla-australia-pty-ltd
Artg Date: 2022-09-06
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

7893c806d294f12e

Type

Standard